Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Halfon

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
European Journal of Gastroenterology & Hepatology|September 23, 2003
Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete responsePhilippe Halfon, Hacene Khiri, Albert Tran, et al.
Journal of Medical Virology|January 26, 2011
Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantationPhilippe Halfon, Pierre Berger, Hacene Khiri, et al.
Vaccine|June 21, 2012
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccinesJoseph Monsonego, Laurent Zerat, Kari Syrjänen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 15, 2010
Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detectionPhilippe Halfon, Dominique Benmoura, Aubert Agostini, et al.
Journal of Hepatology|October 20, 2007
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006Patrice Cacoub, Philippe Halfon, Eric Rosenthal, et al.
BMJ Open|February 11, 2025
Cluster analysis of post-COVID-19 physical and mental health outcomes 3-6 months after SARS-CoV-2 infection: results of the French Prospective ALCOVID Cohort StudyThomas Escoda, Laurent Chiche, Hervé Faralli, et al.
Cancer Biomarkers : Section a of Disease Markers|January 26, 2011
Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears referred to colposcopyPhilippe Halfon, Dominique Benmoura, Aubert Agostini, et al.
Journal of Clinical Microbiology|March 30, 2002
Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unitPhilippe Halfon, Christa Roubicek, Victoria Gerolami, et al.
Antiviral Therapy|October 9, 2009
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 StudyPatrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.
Journal of Medical Virology|August 29, 2025
Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma PatientSolenn Klutsch, Céline Boschi, Anne Motte, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
European Journal of Gastroenterology & Hepatology|September 23, 2003
Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete responsePhilippe Halfon, Hacene Khiri, Albert Tran, et al.
Journal of Medical Virology|January 26, 2011
Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantationPhilippe Halfon, Pierre Berger, Hacene Khiri, et al.
Vaccine|June 21, 2012
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccinesJoseph Monsonego, Laurent Zerat, Kari Syrjänen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 15, 2010
Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detectionPhilippe Halfon, Dominique Benmoura, Aubert Agostini, et al.
Journal of Hepatology|October 20, 2007
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006Patrice Cacoub, Philippe Halfon, Eric Rosenthal, et al.
BMJ Open|February 11, 2025
Cluster analysis of post-COVID-19 physical and mental health outcomes 3-6 months after SARS-CoV-2 infection: results of the French Prospective ALCOVID Cohort StudyThomas Escoda, Laurent Chiche, Hervé Faralli, et al.
Cancer Biomarkers : Section a of Disease Markers|January 26, 2011
Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears referred to colposcopyPhilippe Halfon, Dominique Benmoura, Aubert Agostini, et al.
Journal of Clinical Microbiology|March 30, 2002
Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unitPhilippe Halfon, Christa Roubicek, Victoria Gerolami, et al.
Antiviral Therapy|October 9, 2009
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 StudyPatrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.
Journal of Medical Virology|August 29, 2025
Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma PatientSolenn Klutsch, Céline Boschi, Anne Motte, et al.
Pageof 16